𝔖 Bobbio Scriptorium

✦ LIBER ✦

An open label pilot study to evaluate the efficacy of lymphoblastoid interferon (L-IFN) in patient with chronic hepatitis C previously treated with recombinant alpha-interferon (R-IFN)

Book ID: 123533273
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 168 KB
Volume: 108
Category: Article
ISSN: 0016-5085
DOI: 10.1016/0016-5085(95)28773-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Fate of antibody to interferon (IFN) in

Fate of antibody to interferon (IFN) in chronic hepatitis C patients treated with recombinant IFN alpha 2 and retreated with lymphoblastoid IFN alpha

✍ Guido Antonelli; Gianluigi Giannelli; Maurizio Currenti; Eleonora Simeoni; Miche 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 392 KB

Prospective, randomised, controlled stud

Prospective, randomised, controlled study of the efficacy of interferon alpha-2b (IFN) plus ribavirin (RIB) in patients with chronic hepatitis C (CHC) ‘non responders’ to IFN

✍ Ricardo Moreno-Otero 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 109 KB

Efficacy of an analysis of lymphocyte su

Efficacy of an analysis of lymphocyte subsets in predicting the clinical response to α-interferon therapy in thalassaemia patients with chronic infection by hepatitis C virus: a pilot study

✍ Giovanna Russo-Mancuso; Felicia Di Gregorio; Enrica Passero; Antonella Sciotto; 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 726 KB

Efficacy and safety of the combination o

Efficacy and safety of the combination of histamine dihydrochloride and interferon (IFN) alpha-2B in a phase II trial in naive patients with chronic hepatitis C: Yoav Lurie, Ronit Pakula, Stephen Malnick, Mark Beer-gabel, Kaplan Medical Center, Rehovot Israel; Kurt R Gehlsen, Maxin Pharmaceuticals, San Diego, CA

📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB

A phase II randomized, double-blind, pla

A phase II randomized, double-blind, placebo-controlled multicenter study of recombinant human interleukin-12 for the treatment of chronic hepatitis C virus infection in patients non-responsive to previous treatment with interferon-alpha with or without ribavirin: Paul J Pockros, John G McHutchison, Scripps Clinic, La Jolla, CA; Chris O'Brien, University of Miami, Miami, FL; Myron Tong, Huntingon Medical Research Institute, Pasadena, CA; Coleman Smith, Minnesota Clinical Research Center, St. Paul, MN; Vinod Rustgi, Metropolitan Research Group, Fairfax, VA; Robert L Carithers, University of Washington Medical Center, Seattle, WA; Elizabeth Olek, Genetics Institute, Cambridge, MA

📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB